
Alcon independent now
After years of toing and froing by its parent company Novartis, Alcon finally debuted as an independent, publicly-traded company on the New York Stock Exchange on 10 April to much rejoicing by staff and city commentators alike.

After years of toing and froing by its parent company Novartis, Alcon finally debuted as an independent, publicly-traded company on the New York Stock Exchange on 10 April to much rejoicing by staff and city commentators alike.

Engineers at the University of California and Harvard Medical School have developed an adhesive gel that encourages the cornea to heal itself following an injury, reducing the need for corneal

A blog for doctors in the US has highlighted the potential data security risks to the medical profession, as more and more wearable health devices become commonplace. In the eye health field,

Proteins in the eye could provide the basis for an accessible, cost-effective test to predict future Alzheimer's disease (AD), according to Boston Medical Centre researchers. Low levels of amyloid-β

A new technique for the treatment of keratoconus using corneal allogenic intrastromal ring segments (CAIRS) followed by crosslinking (CXL) may be a simple, safe, and effective option for treating

Community eye health representatives in the UK have told the National Health Service (NHS) they want funding for IT connectivity between optical practices and the rest of the NHS before the end of this financial year.

Aldeyra Therapeutics has announced positive results from the Phase 3 ALLEVIATE Trial of reproxalap topical ophthalmic solution in patients with allergic conjunctivitis. "This confirms the potential

A Queensland University of Technology PhD student working to prevent diabetes-related blindness in Indigenous communities is the inaugural winner of a new Queensland Women in STEM award

New research led by the Centre for Eye Research Australia will test the effectiveness of an artificial intelligence (AI)-based technology in providing much-needed eye screening services in remote and

Alnylam and Regeneron announced they have joined forces in a multi-million dollar deal to discover, develop and commercialise new gene-regulating drugs including some aimed at combating eye

Combining smart contact lenses with smart glasses could prevent or lessen eye strain and make virtual reality (VR) solutions a practical option for everyday use, VR developer Innovega said in a white

An NIH study has found there is no evidence that calcium increases the risk of age-related macular degeneration (AMD).The findings contradict an earlier study indicating that high levels of calcium